Project co Financed

Project Code | LISBOA-01-02B7-FEDER-055168
Main Objective | Strengthening research, technological development and innovation
Intervention Region | Lisbon
Beneficiary Entity | Delox – Research, Processes and Scientific Equipment, Ltd.
Approval Date | 02-06-2020
Start Date | 01-06-2020
Completion Date | 30-11-2020
Total Eligible Cost | €291,698.11
European Union Financial Support | €233,358.48
National/Regional Public Financial Support | Not applicable

Objectives

Delox joined forces with the University of Lisbon, the Portuguese Army and the Armed Forces Hospital (partner) to develop the RECYCLE project, which consists of the development of two mask biodecontamination devices, enabling their safe reuse, particularly in situations where mask shortages are critical.

Activities

The activities are scheduled to be carried out over a period of six months. This is expected to accelerate the achievement of results and provide a solution to support the response to COVID-19.

Expected/Achieved Results

This project will result in two devices based on the dryVHP technology developed by Delox. These compact and low-cost devices will be capable of decontaminating up to 200 masks in two hours in a hospital environment or up to four masks in thirty minutes in either hospital or domestic settings. The consortium has a long history of collaboration and, collectively, the participating institutions bring together the material resources and, most importantly, the human resources required for the successful implementation of this project.

Project Code | LISBOA-01-0247-FEDER-072326
Main Objective | Strengthening research, technological development and innovation
Intervention Region | Lisbon
Beneficiary Entity | Delox – Research, Processes and Scientific Equipment, Ltd.
Approval Date | 03-05-2021
Start Date | 05-07-2021
Completion Date | 30-06-2023
Total Eligible Cost | €580,028.82
European Union Financial Support | ERDF – €290,014.31

Objectives

Delox plans to launch two bio-decontamination devices: one device for small volumes, intended for laboratory equipment, and another for large volumes, designed for hospital rooms. These efficient, compact and low-cost devices will be based on the proprietary dryVHP technology.

Activities

The activities are divided into R&D activities, such as prototype development and pre-industrialization, testing activities such as field trials and pilot projects, and dissemination activities.

Expected/Achieved Results

In 2022, Delox plans to enter the market with a bio-decontamination device for laboratory equipment that has already been fully tested and certified. The bio-decontamination device for hospital rooms will be prototyped and further refined so that it can be the subject of a pilot project in 2023, the year in which it is expected to enter the market.